Most Read Articles
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Serrated polyps up long-term risk of colorectal cancer

29 Aug 2020

Having proximal serrated polyps (SPs), particularly large ones, is a risk factor for the long-term development of colorectal cancer (CRC), a recent study has found.

Researchers conducted a retrospective analysis of 233,393 individuals who had undergone colonoscopy. Participants were categorized according to the size (large, small, or unknown) and location (proximal or distal) of SP. The outcome of interest was the development of CRC >1 year after the first colonoscopy.

Over a median follow-up of 3.6 years, 445 patients developed CRC more than a year after colonoscopy. The 5-year cumulative incidence rate for CRC varied according to the presence of polyps, and their size and location. Those with no polyps, for instance, had a cumulative incidence rate of 1.2 per 1,000 persons.

In those with proximal small, proximal large, and distal SPs, the resulting cumulative incidence rates were 2.5, 6.2, and 1.7 per 1,000 persons, respectively.

Cox proportional hazards analysis confirmed these findings. Having SP alone increased the long-term risk of incident CRC (adjusted hazard ratio [HR], 1.7, 95 percent confidence interval [CI], 1.3–2.2). This effect was amplified by the co-presence of adenoma (adjusted HR, 3.1, 95 percent CI, 2.4–4.0).

Further stratification showed that small proximal (adjusted HR, 2.6, 95 percent CI, 1.7–3.9) and large proximal (adjusted HR, 8.0, 95 percent CI, 3.9–16.1) SPs significantly increased the risk of incident CRC ≥3 years after the initial colonoscopy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.